Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial, Jama, vol.288, pp.321-333, 2002. ,
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial, Jama, vol.291, pp.1701-1712, 2004. ,
Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women, Current Opinion in Hematology, vol.17, issue.5, pp.457-463, 2010. ,
DOI : 10.1097/MOH.0b013e32833c07bc
Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk, The Lancet, vol.362, issue.9382, pp.428-432, 2003. ,
DOI : 10.1016/S0140-6736(03)14066-4
URL : https://hal.archives-ouvertes.fr/hal-01026273
Hormone Therapy and Venous Thromboembolism Among Postmenopausal Women: Impact of the Route of Estrogen Administration and Progestogens: The ESTHER Study, Circulation, vol.115, issue.7, pp.840-845, 2007. ,
DOI : 10.1161/CIRCULATIONAHA.106.642280
URL : https://hal.archives-ouvertes.fr/hal-00688234
Postmenopausal Hormone Therapy and Risk of Idiopathic Venous Thromboembolism: Results From the E3N Cohort Study, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.30, issue.2, pp.340-345, 2010. ,
DOI : 10.1161/ATVBAHA.109.196022
URL : https://hal.archives-ouvertes.fr/inserm-01142846
Hormone replacement therapy and the risk of venous thromboembolism: a population-based study, J Thromb Haemost, vol.8, pp.979-986, 2010. ,
Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis, BMJ, vol.336, issue.7655, pp.1227-1231, 2008. ,
DOI : 10.1136/bmj.39555.441944.BE
URL : https://hal.archives-ouvertes.fr/inserm-01142884
Venous Thrombosis and Conjugated Equine Estrogen in Women Without a Uterus, Archives of Internal Medicine, vol.166, issue.7, pp.772-780, 2006. ,
DOI : 10.1001/archinte.166.7.772
Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women, BMJ, vol.335, issue.7613, p.239, 2007. ,
DOI : 10.1136/bmj.39266.425069.AD
Menopausal Hormone Therapy and Risk of Endometrial Carcinoma Among Postmenopausal Women in the European Prospective Investigation into Cancer and Nutrition, American Journal of Epidemiology, vol.172, issue.12, pp.1394-1403, 2010. ,
DOI : 10.1093/aje/kwq300
Pharmacological profile of progestins, Maturitas, vol.47, issue.4, pp.277-283, 2004. ,
DOI : 10.1016/j.maturitas.2004.01.001
Different cardiovascular effects of progestins according to structure and activity, Climacteric, vol.100, issue.sup1, pp.96-101, 2009. ,
DOI : 10.1161/hc4801.099737
New Progestogens, Drugs & Aging, vol.46, issue.1, pp.865-883, 2004. ,
DOI : 10.2165/00002512-200421130-00004
Risk of venous thromboembolism in users of hormone replacement therapy, The Lancet, vol.348, issue.9033, pp.977-980, 1996. ,
DOI : 10.1016/S0140-6736(96)07113-9
Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens, The Lancet, vol.348, issue.9033, pp.981-983, 1996. ,
DOI : 10.1016/S0140-6736(96)07114-0
Hormone replacement therapy and risk of venous thromboembolism: population based case-control study, BMJ, vol.314, issue.7083, pp.796-8001581, 1997. ,
DOI : 10.1136/bmj.314.7083.796
Estrogen Plus Progestin and Risk of Venous Thrombosis, JAMA, vol.292, issue.13, pp.1573-1580, 2004. ,
DOI : 10.1001/jama.292.13.1573
The effects of the addition of nomegestrol acetate to post-menopausal oestrogen therapy, Maturitas, vol.11, issue.1, pp.21-346, 1989. ,
DOI : 10.1016/0378-5122(89)90117-5
Indicators of lifetime endogenous estrogen exposure and risk of venous thromboembolism, Journal of Thrombosis and Haemostasis, vol.85, issue.1, pp.71-7621, 2003. ,
DOI : 10.1046/j.1365-2265.1997.2601068.x
URL : https://hal.archives-ouvertes.fr/hal-00688975
The Effects of Tibolone in Older Postmenopausal Women, New England Journal of Medicine, vol.359, issue.7, pp.697-708, 2008. ,
DOI : 10.1056/NEJMoa0800743
Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial, The Lancet Oncology, vol.10, issue.2, pp.135-146, 2009. ,
DOI : 10.1016/S1470-2045(08)70341-3
Cardiovascular risk factors and combined estrogen-progestin replacement therapy: a placebo-controlled study with nomegestrol acetate and estradiol, Fertility and Sterility, vol.64, issue.5, pp.957-962, 1995. ,
DOI : 10.1016/S0015-0282(16)57909-6
The effects of estradiol valerate plus medroxyprogesterone acetate and conjugated estrogens plus medrogestone on climacteric symptoms and metabolic variables in perimenopausal women, Acta Obstetricia et Gynecologica Scandinavica, vol.75, issue.4, pp.386-393, 1996. ,
DOI : 10.3109/00016349609033337
Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women, N Engl J Med, vol.3, issue.336, pp.683-690, 1997. ,
Effects of Oral and Transdermal Estrogen/Progesterone Regimens on Blood Coagulation and Fibrinolysis in Postmenopausal Women : A Randomized Controlled Trial, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.17, issue.11, pp.3071-3078, 1997. ,
DOI : 10.1161/01.ATV.17.11.3071
The Effects of Hormone Replacement Therapy on Hemostatic Variables in Women with Angiographically Verified Coronary Artery Disease, Thrombosis Research, vol.98, issue.1, pp.19-27, 2000. ,
DOI : 10.1016/S0049-3848(99)00233-9
Postmenopausal Hormone Replacement Therapy Increases Coagulation Activity and Fibrinolysis, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.20, issue.5, pp.1404-140929, 2000. ,
DOI : 10.1161/01.ATV.20.5.1404
URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.619.1709
Short-and long-term effects of hormone replacement therapy on cardiovascular risk factors in postmenopausal women, Chang Gung Med J, vol.24, pp.431-439, 2001. ,
Effects of hormone replacement on hemostasis in spontaneous menopause, Menopause, vol.8, issue.2, pp.135-140, 2001. ,
DOI : 10.1097/00042192-200103000-00009
Hormone replacement therapy in healthy postmenopausal women: a randomized, placebo-controlled study of effects on coagulation and fibrinolytic factors, Journal of Internal Medicine, vol.2, issue.3, pp.237-246, 2001. ,
DOI : 10.1016/S0029-7844(96)00530-3
Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial, British Journal of Haematology, vol.147, issue.2, pp.415-420, 2001. ,
DOI : 10.1016/S0140-6736(99)06092-4
Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism, Fertility and Sterility, vol.76, issue.1, pp.13-24, 2001. ,
DOI : 10.1016/S0015-0282(01)01829-5
The Effects of Transdermal Estradiol in Combination with Oral Norethisterone on Lipoproteins, Coagulation, and Endothelial Markers in Postmenopausal Women with Type 2 Diabetes: A Randomized, Placebo-Controlled Study, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.3, pp.1140-11431017, 2001. ,
DOI : 10.1210/jcem.86.3.7297
Effect of Oral and Transdermal Estrogen Replacement Therapy on Hemostatic Variables Associated With Venous Thrombosis: A Randomized, Placebo-Controlled Study in Postmenopausal Women, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.23, issue.6, pp.1671-16761116, 2003. ,
DOI : 10.1161/01.ATV.0000074146.36646.C8
Randomized trial of effect of transdermal continuous combined hormone replacement therapy on cardiovascular risk markers, British Journal of Haematology, vol.2, issue.3, pp.802-808, 2004. ,
DOI : 10.1016/S0925-4439(97)00097-5
Randomized trial of effects of continuous combined HRT on markers of lipids and coagulation in women with acute coronary syndromes: WHISP Pilot Study, European Heart Journal, vol.27, issue.17, pp.2046-2053, 2006. ,
DOI : 10.1093/eurheartj/ehl183
Effects of four different regimens of hormone replacement therapy on hemostatic parameters: A prospective randomized study, Maturitas, vol.53, issue.3, pp.267-273, 2006. ,
DOI : 10.1016/j.maturitas.2005.05.010
Effect of estrogen-progestin hormonal replacement therapy on blood coagulation and fibrinolysis in postmenopausal women, Clinics, vol.62, issue.5, pp.553-560, 2007. ,
DOI : 10.1590/S1807-59322007000500004
A Canadian multicentre prospective study on the effects of an oral contraceptive containing 3 mg drospirenone and 30 ??g ethinyl oestradiol on somatic and psychological symptoms related to water retention and on body weight, The European Journal of Contraception & Reproductive Health Care, vol.97, issue.9, pp.220-228, 2007. ,
DOI : 10.1080/13625180008500387
Inhibitors and activation markers of the haemostatic system during hormone therapy: a comparative study of oral estradiol (2 mg)/ dydrogesterone and estradiol (2 mg)/ trimegestone The effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on cardiovascular metabolic risk factors, Thromb Haemost Climacteric, vol.100, issue.11, pp.253-260489, 2008. ,
Effect of progestogen and progestogen type on hemostasis measures in postmenopausal women, Menopause, vol.15, issue.6, pp.1145-1150, 2008. ,
DOI : 10.1097/gme.0b013e3181775eca
Optimal tolerability of ultra-low-dose continuous combined 17??-estradiol and norethisterone acetate: laboratory and safety results, Climacteric, vol.21, issue.1, pp.34-44, 2010. ,
DOI : 10.1016/S0015-0282(01)01791-5
Activated protein C resistance among postmenopausal women using transdermal estrogens, Menopause, vol.17, issue.6, pp.1122-1127, 2010. ,
DOI : 10.1097/gme.0b013e3181e102eb
URL : https://hal.archives-ouvertes.fr/inserm-01148711
Hormone replacement therapy and hypercoagulability. Results from the Prospective Collaborative Danish Climacteric Study, BJOG: An International Journal of Obstetrics and Gynaecology, vol.83, issue.6, pp.541-547, 2003. ,
DOI : 10.1046/j.0007-1048.2002.03356.x
Effects of tibolone and continuous combined hormone replacement therapy on parameters in the clotting cascade: a multicenter, double-blind, randomized study, Fertility and Sterility, vol.74, issue.1, pp.10-19, 2000. ,
DOI : 10.1016/S0015-0282(00)00587-2
Haemostatic risk factors in healthy postmenopausal women taking hormone replacement therapy, Maturitas, vol.43, issue.2, pp.125-133, 2002. ,
DOI : 10.1016/S0378-5122(02)00202-5
Significant Differential Effects of Hormone Therapy or Tibolone on Markers of Cardiovascular Disease in Postmenopausal Women: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.23, issue.10, pp.1889-1894, 2003. ,
DOI : 10.1161/01.ATV.0000091502.96745.95
Significant differential effects of lower doses of hormone therapy or tibolone on markers of cardiovascular disease in post-menopausal women: a randomized, double-blind, crossover study, European Heart Journal, vol.26, issue.14, pp.1362-1368, 2005. ,
DOI : 10.1093/eurheartj/ehi311
Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation, Maturitas, vol.55, issue.3, pp.278-287, 2006. ,
DOI : 10.1016/j.maturitas.2006.04.012
Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system, Thrombosis and Haemostasis, vol.97, pp.938-943, 2007. ,
DOI : 10.1160/TH06-11-0632
Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis, Thrombosis Research, vol.120, issue.3, pp.371-379, 2007. ,
DOI : 10.1016/j.thromres.2006.10.013
Comparison of the effects of tibolone and estrogen therapy on hemostasis in surgical menopause: a randomized, double-blind, placebo-controlled study, Fertility and Sterility, vol.87, issue.4, pp.842-848, 2007. ,
DOI : 10.1016/j.fertnstert.2006.08.090